1-20 of 55
Authors: U. Mrowietz
Journal Article
Association of sex and systemic therapy treatment outcomes in psoriasis: a two‐country, multicentre, prospective, noninterventional registry study Get access
British Journal of Dermatology, Volume 185, Issue 6, 1 December 2021, Pages 1160–1168, https://doi.org/10.1111/bjd.20387
Published: 01 December 2021
Journal Article
Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement
British Journal of Dermatology, Volume 185, Issue 3, 1 September 2021, Pages 605–615, https://doi.org/10.1111/bjd.19899
Published: 01 September 2021
Journal Article
Secukinumab 2‐weekly vs. 4‐weekly dosing in patients with plaque‐type psoriasis: results from the randomized GAIN study Get access
British Journal of Dermatology, Volume 184, Issue 5, 1 May 2021, Pages 849–856, https://doi.org/10.1111/bjd.19398
Published: 01 May 2021
Journal Article
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 548–550, https://doi.org/10.1111/bjd.19558
Published: 01 March 2021
Journal Article
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study Get access
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 425–436, https://doi.org/10.1111/bjd.19262
Published: 01 March 2021
Includes: Multimedia
Journal Article
A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment
British Journal of Dermatology, Volume 182, Issue 4, 1 April 2020, Pages 869–879, https://doi.org/10.1111/bjd.18384
Published: 01 April 2020
Journal Article
A trial to compare the biologic drug ixekizumab with two other treatments for psoraisis, fumaric acid esters and methotrexate Get access
British Journal of Dermatology, Volume 182, Issue 4, 1 April 2020, Page e138, https://doi.org/10.1111/bjd.18905
Published: 01 April 2020
Journal Article
比较生物制剂依奇珠单抗与其他两种治疗银屑病的药物富马酸酯和甲氨蝶呤的试验 Get access
British Journal of Dermatology, Volume 182, Issue 4, 1 April 2020, Page e148, https://doi.org/10.1111/bjd.18915
Published: 01 April 2020
Journal Article
苏金单抗持续用于治疗银屑病的疗效 Get access
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Page e39, https://doi.org/10.1111/bjd.18670
Published: 01 January 2020
Journal Article
The efficacy of secukinumab with continued use in the treatment of psoriasis Get access
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Page e22, https://doi.org/10.1111/bjd.18653
Published: 01 January 2020
Journal Article
Continued treatment with secukinumab is associated with high retention or regain of response Get access
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Pages 67–75, https://doi.org/10.1111/bjd.17991
Published: 01 January 2020
Includes: Multimedia
Journal Article
Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials
British Journal of Dermatology, Volume 181, Issue 5, 1 November 2019, Pages 967–975, https://doi.org/10.1111/bjd.17919
Published: 01 November 2019
Journal Article
Effects of psychosocial interventions on patient‐reported outcomes in patients with psoriasis: a systematic review and meta‐analysis Get access
British Journal of Dermatology, Volume 181, Issue 5, 1 November 2019, Pages 939–945, https://doi.org/10.1111/bjd.17272
Published: 01 November 2019
Journal Article
Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial Get access
British Journal of Dermatology, Volume 181, Issue 5, 1 November 2019, Pages 954–966, https://doi.org/10.1111/bjd.17351
Published: 01 November 2019
Journal Article
Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways
British Journal of Dermatology, Volume 181, Issue 4, 1 October 2019, Pages 859–862, https://doi.org/10.1111/bjd.18001
Published: 01 October 2019
Journal Article
Topology of psoriasis in routine care: results from high‐resolution analysis of 2009 patients Get access
British Journal of Dermatology, Volume 181, Issue 2, 1 August 2019, Pages 358–365, https://doi.org/10.1111/bjd.17403
Published: 01 August 2019
Journal Article
银屑病严重程度的定义 Get access
British Journal of Dermatology, Volume 179, Issue 6, 1 December 2018, Page e259, https://doi.org/10.1111/bjd.17304
Published: 01 December 2018
Journal Article
Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long‐term psoriasis management Get access
British Journal of Dermatology, Volume 179, Issue 6, 1 December 2018, Pages 1385–1391, https://doi.org/10.1111/bjd.17128
Published: 01 December 2018
Journal Article
Definition of psoriasis severity Get access
British Journal of Dermatology, Volume 179, Issue 6, 1 December 2018, Page e244, https://doi.org/10.1111/bjd.17289
Published: 01 December 2018
Journal Article
Psoriasis, stress, age and more Get access
British Journal of Dermatology, Volume 178, Issue 4, 1 April 2018, Pages 830–831, https://doi.org/10.1111/bjd.16413
Published: 01 April 2018
